Cresco Labs (CRLBF) Cash from Operations (2019 - 2025)
Cresco Labs (CRLBF) posted Cash from Operations of 27432000.0 for Q4 2025, up 345.04% on a QoQ basis from 6164000.0 in Q3 2025, and down 6.97% year-over-year from 29486000.0 in Q4 2024.
Cresco Labs (CRLBF) Cash from Operations (2019 - 2025) Analysis & Trends
Cresco Labs' Cash from Operations history runs 7 years deep, the most recent figure standing at 27432000.0 for Q4 2025.
- Quarterly Cash from Operations fell 6.97% year-over-year to 27432000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 112445000.0 (down 3.21% YoY) and the FY2025 annual result came in at 72890000.0, down 44.98% from the prior year.
- Cash from Operations was 27432000.0 for Q4 2025 at Cresco Labs, up from 6164000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 49363000.0 in Q3 2024 and bottomed at 43191000.0 in Q2 2021.
- A 5-year average of 16002787.16 and a median of 19277000.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 190.91% — and 2024, when it soared 993.24%.
- Cresco Labs' Cash from Operations stood at 37653000.0 in 2021, then slumped by 90.36% to 3631000.0 in 2022, then slumped by 190.91% to 3301000.0 in 2023, then surged by 993.24% to 29486000.0 in 2024, then dropped by 6.97% to 27432000.0 in 2025.
- Business Quant data shows CRLBF's Cash from Operations at 27432000.0 in Q4 2025, 6164000.0 in Q3 2025, and 29486000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.43 Mn |
| Dec 31, 2025 | 27.43 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Sep 30, 2021 | 5.62 Mn |